FDA.reportPublic FDA data

26 ML ustekinumab-kfce 5 MG/ML Injection

RxCUI
2705581
RxNorm name
26 ML ustekinumab-kfce 5 MG/ML Injection
Display name
26 ML ustekinumab-kfce 5 MG/ML Injection
Full name
26 ML ustekinumab-kfce 5 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761406Yesintekustekinumab-kfce351(k) InterchangeableRx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
12a75613-ee33-d30a-215b-2a51cfa19b00ustekinumab-kfce 130 MG in 26 ML Injection [PSN] · 26 ML ustekinumab-kfce 5 MG/ML Injection [SCD] · ustekinumab-kfce 130 MG per 26 ML Injection [SY]39These highlights do not include all the information needed to use YESINTEK safely and effectively. See full prescribing information for YESINTEK. YESINTEK TM (ustekinumab-kfce) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2024 YESINTEK TM (ustekinumab-kfce) is biosimilar* to STELARA ® (ustekinumab).20251209